Abstracts - faqs.org

Abstracts

Business

Search abstracts:
Abstracts » Business

Lockheed says F/A-22 raptor production on track; IOT&E goes well

Article Abstract:

Lockheed Martin Corp. was on track to produce the 19 F/A-22 Raptor fighter aircraft and it rolled the 11th Raptor built in 2004 off the line. The initial operational testing and evaluation (IOT&E) was well performed as per expectations and it was believed that the 19 F/A-22 Raptor fighter aircraft plays a critical role.

Author: Ahearn, Dave
Publisher: King Publishing Group
Publication Name: Defense Today
Subject: Business
ISSN:
Year: 2004

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Lockheed says efficiency saves billions at F/A-22 Raptor plant

Article Abstract:

Lockheed Martin reported that its investments in smarter production practices would save $3.8 billion over the life of the F/A-22 Raptor program. The Raptor is the most advanced fighter aircraft in the world and is expected to set standard for air combat, including ground attack, for years to come.

Author: Laurenzo, Ron
Publisher: King Publishing Group
Publication Name: Defense Today
Subject: Business
ISSN:
Year: 2004
Financial management, Company investment, Investments

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA



Subjects list: United States, Product development, Aircraft industry, Lockheed Martin Corp., F/A-22 (Aircraft)
Similar abstracts:
  • Abstracts: Lockheed announces 4 successful warhead tests. Lockheed announces three successful rocket tests. Lockheed, Boeing complete successful weapons tests
  • Abstracts: Lockheed rejects assertions that C-130J is flawed. Lockheed Martin begins assembly of first JSF. Lockheed begins systems work on helos
  • Abstracts: England: Second JSF engine not worth the cost. Resumed test flights may not avert Raptor cuts
  • Abstracts: Polyclonal antibodies step out of the shadows. Supreme Court boosts licensees in biotech patent battles. GlaxoSmithKline cancer drug threatens Herceptin market
  • Abstracts: Lockheed LCS difficult for enemy to target: Company. Silorsky rebuts Lockheed on Marine One fight. Around 500 to 1000 must be cut from JSF: Lockheed
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.
Some parts © 2025 Advameg, Inc.